A biostatistician on where real-world data changes outcomes, and where FDA still won’t accept it as a trial comparator.
- AI Governance Is Becoming A Competitive Edge In Trials
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Regulatory Binder Checklist For Clinical Trial Sites
By following this checklist, research teams can enhance organizational efficiency, maintain compliance with regulatory standards, and confidently navigate the complexities of documentation management.
-
What Patients Are Asking For In Clinical Trials
Global insights show how travel demands, uneven compensation, and overlooked caregiver burden undermine trial participation — making flexible, patient-centered approaches essential.
-
Why Oncology Drug Development Lags In Digital Biomarkers
Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.
-
Why ePROs In Oncology Are Perfect For Capturing The Patient's Voice
Recently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.
-
The Power Of Predictive Analytics In Clinical Trial Design
Discover how predictive analytics address clinical trial challenges by applying statistical and modeling techniques to current and historical data.
-
Reducing Risks And Accelerating Study Startup Through An eCOA Library
Find out how the shift towards a more patient-centric drug development landscape has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.
-
Developing Drugs For Rare Diseases: Generating Clinical Evidence
For rare diseases, scientific breakthroughs often stall before reaching patients. A new approach to generating clinical evidence could change that trajectory.
-
Three Ways That eCOA Improves Data Quality
Follow this quick guide to the key ways that eCOA works to help all study stakeholders (patients, caregivers, study teams, etc.) produce better data.
-
Where PRO Strategy Goes Wrong
PRO and COA strategy is now central to trial success. Organizations that capture meaningful patient experience data will gain stronger evidence and a regulatory advantage.
-
Why Protocol‑Driven eSource Solves Data Capture For 80% Of Sites
Designing data capture around study protocols boosts data quality and real‑time visibility. Reducing transcription and aligning workflows helps teams improve compliance and speed decisions.
RECENT NEWSLETTERS
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations